NASDAQ · CLYM
Climb Bio, Inc.
Healthcare · Biotechnology
$11.00
Up+$0.14 (+1.29%)
Updated Oct 12, 2026, 11:51 AM
SID Score
4.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 157.17M
- P/E ratio
- -3.33
- Dividend yield
- 0.00%
- 52-week range
- $5.87 – $18.33
- Volume
- 638.14K
- Avg. volume
- 598.77K
Price performance · CLYM
CLYM price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
CLYM closed at $11.00 after 20 trading sessions, down 24.45% for the selected period.
- Last close
- $11.00
- Period change
- -24.45%
- Period low
- $10.68
- Period high
- $14.56
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $10.81 | $11.30 | $10.75 | $11.00 | 638.14K |
| Oct 8, 2026 | $10.55 | $11.00 | $10.27 | $10.86 | 1.15M |
| Oct 7, 2026 | $10.43 | $10.945 | $10.34 | $10.71 | 755.81K |
| Oct 6, 2026 | $11.12 | $11.25 | $10.64 | $10.68 | 954.53K |
| Oct 5, 2026 | $10.94 | $11.20 | $10.70 | $11.05 | 1.21M |
| Oct 2, 2026 | $11.29 | $11.29 | $10.73 | $10.94 | 1.58M |
| Oct 1, 2026 | $11.39 | $11.67 | $11.03 | $11.07 | 953.16K |
| Sep 30, 2026 | $11.69 | $11.93 | $11.32 | $11.47 | 1.41M |
| Sep 29, 2026 | $11.79 | $11.805 | $11.31 | $11.50 | 1.14M |
| Sep 28, 2026 | $11.57 | $11.93 | $11.3898 | $11.74 | 811.3K |
| Sep 25, 2026 | $11.89 | $11.92 | $11.53 | $11.66 | 1.53M |
| Sep 24, 2026 | $12.35 | $12.42 | $11.38 | $11.89 | 1.87M |
| Sep 23, 2026 | $14.29 | $14.39 | $12.06 | $12.52 | 2.14M |
| Sep 22, 2026 | $13.75 | $14.29 | $13.63 | $14.21 | 930.13K |
| Sep 21, 2026 | $14.13 | $14.23 | $13.545 | $13.64 | 1.22M |
| Sep 18, 2026 | $14.15 | $14.44 | $13.92 | $14.05 | 4.05M |
| Sep 17, 2026 | $14.49 | $14.655 | $13.765 | $14.06 | 1.4M |
| Sep 16, 2026 | $14.00 | $14.55 | $13.865 | $14.11 | 2.62M |
| Sep 15, 2026 | $14.705 | $14.705 | $13.375 | $13.91 | 1.55M |
| Sep 14, 2026 | $14.49 | $14.96 | $14.30 | $14.56 | 1.09M |
Latest CLYM news
The latest Smart Investors Daily articles mentioning CLYM.
Stock researchMarket Activity · Options
Company
Market Activity
Research & News

